Akt and PTEN: New diagnostic markers of non‐small cell lung cancer?
- 1 October 2001
- journal article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 5 (4) , 430-433
- https://doi.org/10.1111/j.1582-4934.2001.tb00178.x
Abstract
We are particularly interested in testing the principles of cell proliferation and apoptosis in the microenvironment of human lung cancers with respect to the cell survival protein Akt 1 and PTEN 2. Akt is a cytosolic protein which promotes cell survival by phosphorylative inactivation of targets in apoptotic pathways. Akt has been found to play a role in the survival of experimental cancer cell lines in breast, prostate, ovary, lung and brain tissue. PTEN is a tumor suppressor gene whose protein product is expressed in inverse proportion to phosphorylated Akt in endometrial and breast cancer cell lines. No studies of the diagnostic significance of Akt and PTEN in human lung cancers have been reported.Keywords
This publication has 6 references indexed in Scilit:
- Phosphatidylinositol 3-Kinase/AKT-mediated Activation of Estrogen Receptor αJournal of Biological Chemistry, 2001
- Activation of Akt (Protein Kinase B) in Mammary Epithelium Provides a Critical Cell Survival Signal Required for Tumor ProgressionMolecular and Cellular Biology, 2001
- PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathwaysHuman Molecular Genetics, 2001
- Profiling the Downstream Genes of Tumor Suppressor PTEN in Lung Cancer Cells by Complementary DNA MicroarrayAmerican Journal of Respiratory Cell and Molecular Biology, 2000
- Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription FactorCell, 1999
- Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTENCell, 1998